Τύπος | HIPRA

who we are

Τύπος

07/17/2023 - 14:43

AEMPS authorizes the clinical trial to study the joint vaccination of HIPRA's COVID-19 vaccine with an influenza vaccine

Ανθρώπινη

Εξερευνήστε

05/29/2023 - 08:15

AEMPS authorizes the clinical trial to study HIPRA's COVID-19 vaccine in adolescents between 12 and 17 years old

Ανθρώπινη

Εξερευνήστε

04/11/2023 - 16:57

The Spanish Prime Minister defines HIPRA’s vaccine as a 'historic milestone' that reinforces the country's leadership in the European health sector

Ανθρώπινη

Εξερευνήστε

03/31/2023 - 14:27

BIMERVAX® has also obtained the approval of the European Commission to be marketed

Ανθρώπινη

Εξερευνήστε

03/30/2023 - 16:00

HIPRA receives positive opinion from European Medicines Agency for its BIMERVAX® COVID-19 Vaccine

Ανθρώπινη

Εξερευνήστε

01/17/2023 - 14:29

HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions was launched in Turkey

Ανθρώπινη

Εξερευνήστε